These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32040954)

  • 1. Proposal of a Panel of Genes Identified by miRNA Profiling as Candidate Prognostic Biomarkers in Lung Carcinoids.
    Rapa I; Votta A; Giorcelli J; Izzo S; Rigutto A; Metovic J; Napoli F; Volante M
    Neuroendocrinology; 2021; 111(1-2):115-122. PubMed ID: 32040954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression.
    Rapa I; Votta A; Felice B; Righi L; Giorcelli J; Scarpa A; Speel EJ; Scagliotti GV; Papotti M; Volante M
    Neuroendocrinology; 2015; 101(3):246-55. PubMed ID: 25791280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Typical Lung Carcinoids with Metastasis: Potential Role of MicroRNAs in the Regulation of Adaptive Immunity Associated with Disease: a Case Study.
    Seneda AL; Lapa RML; Felix TF; Minutentag IW; Campos CF; Oliveira RA; Oliveira CC; Hasimoto ÉN; Cataneo DC; Cataneo AJM; De Faveri J; Drigo SA; Mur LAJ; Reis PP
    Cell Physiol Biochem; 2021 Jan; 55(S2):1-12. PubMed ID: 33398982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.
    Alcala N; Leblay N; Gabriel AAG; Mangiante L; Hervas D; Giffon T; Sertier AS; Ferrari A; Derks J; Ghantous A; Delhomme TM; Chabrier A; Cuenin C; Abedi-Ardekani B; Boland A; Olaso R; Meyer V; Altmuller J; Le Calvez-Kelm F; Durand G; Voegele C; Boyault S; Moonen L; Lemaitre N; Lorimier P; Toffart AC; Soltermann A; Clement JH; Saenger J; Field JK; Brevet M; Blanc-Fournier C; Galateau-Salle F; Le Stang N; Russell PA; Wright G; Sozzi G; Pastorino U; Lacomme S; Vignaud JM; Hofman V; Hofman P; Brustugun OT; Lund-Iversen M; Thomas de Montpreville V; Muscarella LA; Graziano P; Popper H; Stojsic J; Deleuze JF; Herceg Z; Viari A; Nuernberg P; Pelosi G; Dingemans AMC; Milione M; Roz L; Brcic L; Volante M; Papotti MG; Caux C; Sandoval J; Hernandez-Vargas H; Brambilla E; Speel EJM; Girard N; Lantuejoul S; McKay JD; Foll M; Fernandez-Cuesta L
    Nat Commun; 2019 Aug; 10(1):3407. PubMed ID: 31431620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Assays to Determine Methylguanine-Methyltransferase Status in Lung Carcinoids and Correlation with Clinical and Pathological Features.
    Vatrano S; Giorcelli J; Votta A; Capone G; Izzo S; Gatti G; Righi L; Napoli F; Scagliotti G; Papotti M; Volante M; Rapa I
    Neuroendocrinology; 2020; 110(1-2):1-9. PubMed ID: 31280263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid.
    Velinovic M; Jankovic R; Jovanovic D; Skodric Trifunovic V; Gavrilovic D; Stojsic J; Cavic M
    J BUON; 2019; 24(1):256-266. PubMed ID: 30941978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung.
    Di Fazio P; Maass M; Roth S; Meyer C; Grups J; Rexin P; Bartsch DK; Kirschbaum A
    Tumour Biol; 2017 Oct; 39(10):1010428317728417. PubMed ID: 29017393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
    Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
    Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploration of pathways involved in lung carcinoid progression using gene expression profiling.
    Swarts DR; Van Neste L; Henfling ME; Eijkenboom I; Eijk PP; van Velthuysen ML; Vink A; Volante M; Ylstra B; Van Criekinge W; van Engeland M; Ramaekers FC; Speel EJ
    Carcinogenesis; 2013 Dec; 34(12):2726-37. PubMed ID: 23929435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
    Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
    Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids.
    Rapa I; Votta A; Gatti G; Izzo S; Buono NL; Giorgio E; Vatrano S; Napoli F; Scarpa A; Scagliotti G; Papotti M; Volante M
    Oncotarget; 2018 Jun; 9(44):27535-27546. PubMed ID: 29938004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 and OTP are strong prognostic markers for pulmonary carcinoids.
    Swarts DR; Henfling ME; Van Neste L; van Suylen RJ; Dingemans AM; Dinjens WN; Haesevoets A; Rudelius M; Thunnissen E; Volante M; Van Criekinge W; van Engeland M; Ramaekers FC; Speel EJ
    Clin Cancer Res; 2013 Apr; 19(8):2197-207. PubMed ID: 23444222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study.
    Mairinger FD; Ting S; Werner R; Walter RF; Hager T; Vollbrecht C; Christoph D; Worm K; Mairinger T; Sheu-Grabellus SY; Theegarten D; Schmid KW; Wohlschlaeger J
    Mod Pathol; 2014 Dec; 27(12):1632-40. PubMed ID: 24875640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
    Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
    Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity.
    Laitinen KL; Soini Y; Mattila J; Pääkkö P
    Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.